Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
Breath test could spot breast cancer without needles
Diagnosis OngoingThis study is testing a new, non-invasive way to detect breast cancer by analyzing a person's breath. Researchers are collecting breath samples from 1,000 women (some with breast cancer, some without) and using a special machine to look for unique chemical patterns. The goal is t…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Diagnosis
Last updated May 27, 2026 11:49 UTC
-
Four-Pronged attack on lung cancer: aspirin, quitting, diet, and exercise put to the test
Prevention OngoingThis study tests whether a program combining low-dose aspirin, help to quit smoking, dietary changes, and increased physical activity can lower inflammation and prevent lung cancer in long-term heavy smokers aged 55 to 75. Two thousand participants will also receive yearly low-do…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated May 31, 2026 15:12 UTC
-
New study aims to match kidney cancer patients to best therapy using advanced testing
Knowledge-focused OngoingThis study looks at 100 people with advanced kidney cancer to find patterns in their blood, tumor tissue, and CT scans that can predict which treatment will work best. Researchers will use computer analysis to combine these data and create a tool to guide first-line therapy choic…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 29, 2026 14:17 UTC
-
Italy launches massive registry to track rare hereditary polyposis
Knowledge-focused OngoingThis study is creating a national Italian registry of 1500 people with familial adenomatous polyposis (FAP) and related conditions. Researchers will collect medical history, genetic data, and treatment outcomes to better understand how the disease progresses and how care can be i…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 27, 2026 23:07 UTC
-
AI and blood tests could make lung cancer screening smarter
Knowledge-focused OngoingThis study tests whether combining artificial intelligence, blood biomarkers, and CT scan features can better predict lung cancer risk in heavy smokers. Researchers will analyze data from 650 participants to see if this approach improves screening accuracy and reduces unnecessary…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 27, 2026 23:06 UTC